Streetbeat News

Assets

ABT

Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 10 years by 1.5% on an annualized basis, producing an average annual return of 11.9%. If an investor had bought $1000 of ABT stock 10 years ago, it would be worth $3,048.01 today.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 7:31 pm

BIDU

A significant amount of unusual options activity has been detected for Baidu (NASDAQ:BIDU), with a bearish stance being taken by a whale investor. Of the 28 strange trades detected, 46% were bullish and 53% were bearish. The total amount for puts was $131,973 and for calls was $2,169,404. The targeted price range for Baidu over the last 3 months has been from $115.0 to $195.0. The current price of BIDU is up 0.9% at $156.76.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 7:12 pm

CRWD

A significant bearish stance has been taken on CrowdStrike Holdings (NASDAQ:CRWD) by a large investor, as observed in the options history. The overall sentiment of these big-money traders is split between 46% bullish and 53% bearish. Whales have been targeting a price range from $100.0 to $190.0 for CrowdStrike Holdings over the last 3 months. The price of CRWD is up 4.02% at $161.85. Needham and JMP Securities have downgraded their actions to Buy and Market Outperform respectively, while Morgan Stanley maintains their Overweight rating.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 7:10 pm

FCX

Freeport-McMoRan (NYSE:FCX) has outperformed the market over the past 5 years by 13.13% on an annualized basis, producing an average annual return of 23.13%. If an investor had bought $1000 of FCX stock 5 years ago, it would be worth $2,899.93 today.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 7:04 pm

FILUSD

In the past 24 hours, the price of Filecoin (CRYPTO: FIL) has fallen by 3.03% to $4.28, continuing its negative trend over the past week with a 6.0% loss. The trading volume for the coin has decreased by 43.0% over the past week, while the circulating supply has increased by 0.15% to 438.58 million, which is 22.36% of its max supply of 1.96 billion. The current market cap ranking for FIL is #31 at $1.88 billion.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 7:04 pm

GILD

Gilead Sciences (NASDAQ:GILD) has outperformed the market over the past 20 years, producing an average annual return of 12.04%. If an investor had bought $1000 of GILD stock 20 years ago, it would be worth $9,920.83 today.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 7:03 pm

AVAXUSD

Avalanche's (CRYPTO: AVAX) price has fallen 3.01% to $12.93 in the past 24 hours, continuing its negative trend over the past week with a 1.0% loss. The trading volume for the coin has fallen 28.0% over the past week, while the circulating supply has increased 0.08% to 346.06 million, making up an estimated 48.06% of its max supply of 720.00 million. The current market cap ranking for AVAX is #19 at $4.47 billion.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 7:02 pm

SOLUSD

Solana's (CRYPTO: SOL) price has decreased by 4.0% over the past 24 hours to $23.88, contrary to its performance over the past week where it has experienced an up-trend of 3.0%. The trading volume for the coin has fallen 10.0% over the past week, moving in tandem with the overall circulating supply of the coin, which has decreased 0.13%. The current market cap ranking for SOL is #10 at $9.66 billion.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 7:00 pm

PNC

A significant amount of unusual options activity has been observed for PNC Financial Services Group (NYSE:PNC), with a predominantly bearish sentiment. Whales have been targeting a price range from $115.0 to $150.0 for PNC over the last 3 months. The current price of PNC is $135.6, up 0.07%. Morgan Stanley maintains an Underweight rating on PNC with a price target of $144, while Credit Suisse maintains a Neutral rating with a price target of $135.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 6:46 pm

HUM

A significant bullish stance has been taken on Humana (NYSE:HUM) by a large investor or institution, as evidenced by unusual options activity. The sentiment among these big-money traders is 67% bullish and 32% bearish. The targeted price range for Humana over the last 3 months has been $360.0 to $520.0. Analysts from Mizuho, UBS, Wells Fargo, and Morgan Stanley maintain a Buy or Overweight rating on Humana, while JP Morgan has downgraded its action to Neutral.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 6:46 pm